Topics

Investigational IBD treatments may bring more relief to patients. Learn more about how Pfizer is researching different ways to hopefully target inflammation associated with IBD: http://bit.ly/2vtlAX6 pic.twitter.com/qzn1MXZtTU

17:04 EST 14 Feb 2020 | Pfizer

Investigational IBD treatments may bring more relief to patients. Learn more about how Pfizer is researching different ways to hopefully target inflammation associated with IBD: http://bit.ly/2vtlAX6 

Original Article: Investigational IBD treatments may bring more relief to patients. Learn more about how Pfizer is researching different ways to hopefully target inflammation associated with IBD: http://bit.ly/2vtlAX6 pic.twitter.com/qzn1MXZtTU

NEXT ARTICLE

More From BioPortfolio on "Investigational IBD treatments may bring more relief to patients. Learn more about how Pfizer is researching different ways to hopefully target inflammation associated with IBD: http://bit.ly/2vtlAX6 pic.twitter.com/qzn1MXZtTU"

Quick Search

Relevant Topic

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...